FDA has authorized marketing of the Hominis Surgical System, a new robotically-assisted surgical device that can help facilitate transvaginal hysterectomy in certain patients.
As NCI employees and others at HHS were receiving notices of termination, national cancer organizations called on Congress “to restore stability to NIH.”
